Sanara MedTech (SMTI) Receivables - Other (2011 - 2024)

Sanara MedTech has reported Receivables - Other for 13 years, with the latest figure at $1.1 million in Q4 2024.

• For the quarter ending Q4 2024, Receivables - Other rose 2132.24% year-over-year to $1.1 million; the trailing twelve-month figure through Dec 2024 stood at $1.1 million (up 2132.24% YoY), and the FY2024 full-year result was $1.1 million, up 2132.24% from the prior year.
• Receivables - Other for Q4 2024 stood at $1.1 million, up from $1.1 million in the prior quarter.
• The five-year high for Receivables - Other was $1.1 million in Q4 2024, with the low at $49344.0 in Q1 2020.
• Historically, Receivables - Other has averaged $177721.5 across 5 years, with a median of $49344.0 in 2020.
• Annual changes were most pronounced in 2023 — Receivables - Other tumbled 50.45% — and 2024, when it surged 2132.24%.
• Sanara MedTech's Receivables - Other stood at $49344.0 in 2020, then soared by 61.7% to $79787.0 in 2021, then climbed by 24.82% to $99594.0 in 2022, then slumped by 50.45% to $49344.0 in 2023, then surged by 2132.24% to $1.1 million in 2024.
• The last three Receivables - Other figures came in at $1.1 million (Q4 2024), $1.1 million (Q3 2024), and $49344.0 (Q4 2023), per Business Quant data.